Patents Assigned to KEM Patent Holdings, LLC
  • METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
    Publication number: 20240108574
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Application
    Filed: December 1, 2023
    Publication date: April 4, 2024
    Applicant: KEM PATENT HOLDINGS, LLC
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 11865209
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: January 9, 2024
    Assignee: KEM PATENT HOLDINGS, LLC
    Inventor: Kenneth Eli Morgenstern
  • METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
    Publication number: 20190224113
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Application
    Filed: April 1, 2019
    Publication date: July 25, 2019
    Applicant: KEM PATENT HOLDINGS, LLC
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 10245226
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: April 2, 2019
    Assignee: KEM PATENT HOLDINGS, LLC
    Inventor: Kenneth Eli Morgenstern
  • METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
    Publication number: 20180207092
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Application
    Filed: March 19, 2018
    Publication date: July 26, 2018
    Applicant: KEM PATENT HOLDINGS, LLC
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 9962332
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: May 8, 2018
    Assignee: KEM Patent Holdings, LLC
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 9452133
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer which comprises administering to the eyes of said patient an effective amount of perchlorate anion.
    Type: Grant
    Filed: April 25, 2005
    Date of Patent: September 27, 2016
    Assignee: KEM Patent Holdings, LLC
    Inventor: Kenneth Eli Morgenstern